A2M and prostate cancer: We, therefore, determined expression of p-AktT308 and AktS473 in prostate cancer cells treated with varying concentrations of α2M* and incubated for 25 min or incubated for varying periods of time with 50 pM of α2M* (Figure 4A and B).